Search Videos and More
High-Risk TAVR: Symptomatic CHF and Severe Aortic Stenosis
In this procedural video, Dr. Deepak Talreja presents a case of Transcatheter Aortic Valve Replacement (TAVR) using the Navitor™ valve in a high-risk patient with severe aortic stenosis.New Developments in the Endovascular Treatment for Ascending and Arch Segment
Dr Animesh Rathore describes the unique challenges faced in the endovascular and/or hybrid repair of the ascending aorta.Key Takeaways from ACC 2025
Sentara cardiologists review a few key points from the late-breaking clinical trials and research presentations from American College of Cardiology 2025.ViMAC-TMVR Via Open Atriotomy
Drs. Christopher M. Sciortino and Matthew R. Summers present a hybrid surgical and percutaneous polyvalvular operation in a high-risk patient with severe Mitral Annular Calcification (MAC).TAVR in High-Risk SAVR Patient
In this case study, interventional cardiologist Dr. Matthew Summers presents the management of a high-risk patient with a prior history of surgical aortic valve replacement (SAVR).Updates from Heart Rhythm Society 2025
Dr. Patel reviews the trials and research from the Heart Rhythm Society Conference of showcase groundbreaking science and life-saving therapies in electrophysiology.Zackary Tushak, MD; Manik Veer, MD; Erich Kiehl, MD; Deepak Talerja, MD; Matthew Summers, MD; Christopher Sciortino, MD Sentara Cardiology
Dr Zachary Tushak introduces the multidisciplinary group at Sentara specializing in the care of the sometimes complex, hypertrophic cardiomyopathy patient, and how the team collaborates for best outcomes.Tetralogy of Fallot in 2025: A Review and What's New Interventionally and Electrically
Dr Ellis & Dr Saini give an update on treatments for tetralogy of fallot.Updates in Leadless CIED Technology
Dr. Erich Kiehl describes transvenous lead systems and cost of CIED complications.Pulsed Field Ablation Explained: The Future of Heart Disease Treatment
Dr. Div Patel dives into the innovative procedure of Pulsed Field Ablation (PFA) and its revolutionary role in treating Atrial Fibrillation (AFib). He explains how PFA is transforming the landscape of AFib ablations, making them safer and more effective.Optimizing Heart Failure Treatment: The Synergy of Device Therapies and Contemporary GDMT
Dr Amin Yeyha discusses the collaboration between heart failure and device specialists to improve patient outcomes by ensuring appropriate timing and sequencing of therapies.Treating Cardiovascular Disease Through Weight Loss
Dr Anjali Gresens discusses weight loss and metabolic wellness in relation to cardiovascular health.